Your session is about to expire
← Back to Search
Behavioural Intervention
Online Writing Intervention for Parent-Child Relationships (SPACES Trial)
N/A
Waitlist Available
Led By John E Pachankis, Ph.D.
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month-post-baseline
Awards & highlights
SPACES Trial Summary
This trial is testing two online writing interventions to improve parental acceptance of SGMY in the Southeast US, with interviews, surveys, and journaling exercises to assess success.
Who is the study for?
This trial is for guardians like parents or grandparents in the Southeast U.S. who care for a sexual and gender minority youth (SGMY) aged 15-29, identify as heterosexual and cisgender, and struggle with accepting their SGMY's identity. Those with active mania, psychosis, suicidality, or unable to consent are excluded.Check my eligibility
What is being tested?
The study is testing two brief online writing interventions aimed at improving acceptance of SGMY by their guardians. Participants will either receive one of these interventions or be placed in a control group without intervention.See study design
What are the potential side effects?
Since this trial involves writing interventions rather than medical treatments, traditional side effects are not expected; however participants may experience emotional discomfort when discussing sensitive topics.
SPACES Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-month-post-baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month-post-baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Parents' Rejecting and Supportive Behaviors Measured By the Parent Non-Acceptance Scale
Secondary outcome measures
Change in Parent Anti-SGM Bias Assessed Using the Lesbian, Gay, Bisexual Affiliate Stigma Measure
Change in Parent Anti-SGM Bias Assessed Using the Social Distance Scale
Change in Parent Depression and Anxiety Using the PROMIS (Patient-Reported Outcomes Measurement Information System®) Depression, Anxiety, and Anger Scales
+15 moreSPACES Trial Design
3Treatment groups
Experimental Treatment
Group I: Neutral WritingExperimental Treatment1 Intervention
Participants in the control condition will be asked to write about what they have done since waking up that morning.
Group II: Expressive WritingExperimental Treatment1 Intervention
Participants in the expressive writing (EW) condition will be instructed to write in a free-form manner about the most stressful aspects of being a parent of an SGMY, following standard EW procedures.
Group III: Attachment-Based WritingExperimental Treatment1 Intervention
Participants in the attachment-based writing (ABW) condition will respond to distinct prompts created for the condition based on components of attachment-based family therapy (ABFT).
Find a Location
Who is running the clinical trial?
Vanderbilt UniversityOTHER
703 Previous Clinical Trials
6,143,218 Total Patients Enrolled
Ben-Gurion University of the NegevOTHER
58 Previous Clinical Trials
2,444,654 Total Patients Enrolled
Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,399 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a guardian of a young person aged 15-29.I am unable to understand and give consent for treatment.My parents do not accept my sexual or gender identity.I identify as heterosexual and cisgender.I am between 15 and 29 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Expressive Writing
- Group 2: Attachment-Based Writing
- Group 3: Neutral Writing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many facilities are providing services related to this clinical trial?
"The current trial is being hosted in four different medical centres; College Park, Nashville and Be'er Sheva with an additional 4 clinics. To reduce travel requirements for participants it's suggested to choose the nearest clinic."
Answered by AI
Are there still opportunities for volunteers to join this experiment?
"This medical trial, that was initially introduced on July 1st 2023 and recently modified in June 16th of the same year, is not presently enrolling patients. However, there are 54 other trials actively looking for participants right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger